|
With clinical trials running over budget and with too few participants, this executive briefing in association with Roche and AstraZeneca promises to provide invaluable advice on producing effective marketing strategies to attract and retain patients. Advice will also be given on how to budget for these strategies. Delegates can not afford to miss this executive briefing if they wish to be at the forefront of successful patient recruitment and retention Kate Shaw has worked in the Pharmaceutical Industry for over 10 years, starting her career as a CRA and now working for Roche Products Ltd as a global project manager managing a number of international studies. She has a great interest in patient recruitment and especially in ensuring that patients get access to novel clinical trials. Ann Coulson is a Clinical Project Manager. For the past 15 years she has worked with Innovex, Glaxo, Bristol Myers and AstraZeneca. Her key areas of expertise are in oncology & cardiovascular drug development programmes. Other key areas have included the EU Clinical Trials Directive as well as extensive line management. Ann currently is the Global Strategic Leader for Clinical Trials Recruitment for AstraZeneca, Research and Development. About Roche Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. About AstraZeneca AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with leading positions in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products.
|